B244 not checked

AOBiome LLC

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
9 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Acne Vulgaris
Main trialPhase 2
“This is a phase 2b, randomized, double-blind, vehicle-controlled clinical trial evaluating the efficacy, safety, and tolerability of B244 compared to vehicle in the treatment of moderate to severe acne vulgaris in adolescents and adults. Participants who meet the study entry criteria will be randomized in a 1:1 ratio to receive twice daily topical doses of B244 O.D. 5.0 or vehicle (control) for 12 weeks.”In the company’s words, NCT07866105 on ClinicalTrials.gov

Other drugs for Acne Vulgaris

All 14 drugs for Acne Vulgaris

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting Aug 2027 Study to Determine Efficacy, Safety, and Tolerability of B244 as a Topical Spray in Subjects With Moderate to Severe Acne Vulgaris
Phase 2/3Completed 19 Jul 2017 Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris
Phase 2Completed 25 Apr 2017 A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
Phase 2Completed 11 Feb 2019 A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
Phase 2Completed 27 Feb 2019 Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Phase 2Completed 17 Jun 2019 Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Phase 2Completed 10 Dec 2021 B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
Phase 1/2Completed 21 Dec 2018 Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Phase 1Completed 18 May 2019 A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow B244

Following is part of Solo: you see every change to B244 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in